Drawing for LEITERS

USPTO serial 97087363

LEITERS

Reviewed by CopyMark Law Group

Reg. 7135500Status 700Registered
Filing date
Status date
Registration date
Aug 15, 2023
Examiner
MACDOUGALL, KIERRA RYNNE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with LEITERS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Janet M. Garetto

Janet M. Garetto NIXON PEABODY LLP70 WEST MADISON STREET, SUITE 5200CHICAGO, IL 60602UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Syringes sold filled with medication for treating a wide variety of conditions and illnesses; Intravenous bags sold filled with medication, namely, antibiotics, anticoagulants, antiemetics, cardio vascular drugs, epidural drugs, local anesthesia drugs, ophthalmology drugs, ophthalmics drugs, and pain management drugs for treating a wide variety of conditions and illnesses; Vials sold filled with medication, namely, antibiotics, anticoagulants, antiemetics, cardio vascular drugs, epidural drugs, local anesthesia drugs, ophthalmology drugs, ophthalmics drugs, and pain management drugs for treating a wide variety of conditions and illnesses; Medical devices, namely, infusion pumps for delivering measured amounts of solutions into the bloodstream over time which are sold filled with medication, namely, antibiotics, anticoagulants, antiemetics, cardio vascular drugs, epidural drugs, local anesthesia drugs, ophthalmology drugs, ophthalmics drugs, and pain management drugs for treating a wide variety of conditions and illnessesACTIVEJan 2, 2018
009Downloadable electronic publications, namely, brochures, magazines and newsletters in the field of training and/or continuing education for compounding pharmacistsACTIVE—
035Pharmacy outsourcing services; pharmaceutical services, namely, processing online and telephone prescription orders in retail and central fill pharmacies; Central fill pharmacy servicesACTIVE—
039Packaging and repackaging of pharmaceutical products for human use to the order and specification of othersACTIVE—
041Providing a blog website featuring non-downloadable publications in the nature of brochures, magazines, newsletters and articles regarding training and/or continuing education for compounding pharmacists in the fields of pharmaceuticals and/or pharmaceutical compounding; Non-downloadable electronic publications in the nature of brochures, magazines and newsletters in the field of training and/or continuation education for compounding pharmacistsACTIVESep 1, 2021
042Development of pharmaceutical preparations and medicinesACTIVEJan 31, 2018
044Pharmaceutical compounding servicesACTIVEJan 31, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 15, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 15, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 30, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 30, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 10, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 21, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 15, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 13, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 13, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 13, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 13, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 13, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 9, 2022ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Aug 23, 2022PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Aug 9, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 1, 2022DOCKASSIGNED TO EXAMINER—
Nov 8, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 26, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance